1. Home
  2. Health
  3. Rare Diseases

MPS (Mucopolysaccharidosis)

Articles and Web sites with information about the different types of mucopolysaccharidosis (MPS).
Hunter Syndrome (MPS II)
Information about Hunter syndrome (mucopolysaccharidosis II), its symptoms, diagnosis, and treatment.
FDA approves Elaprase for Hunter syndrome
News brief about the FDA marketing approval of Elaprase for treatment of Hunter syndrome.
TKT reports results of I2S trial for Hunter syndrome
News brief about TKT's Phase III clinical trial of iduronate-2-sulfatase (I2S). TKT (now Shire) has submitted I2S (trade name: Elaprase) to both the EMEA and FDA for marketing approval.
Hurler Syndrome (MPS I)
Article describes Hurler syndrome (MPS I), its symptoms, diagnosis, and treatment.
FDA approval for Aldurazyme for Hurler syndrome
News brief about the approval of Aldurazyme for treatment of Hurler syndrome (MPS I).
MPS VI (Maroteaux-Lamy Syndrome)
Site promotes awareness and diagnosis of Maroteaux-Lamy syndrome (MPS VI); provides information, newsletter, resources, and support.
BioMarin receives FDA approval for Naglazyme for MPS VI
News brief about FDA approval of Naglazyme.
Morquio Syndrome (MPS IV)
Information from the National MPS Society about Morquio syndrome.
Sanfilippo Syndrome (MPS III)
Information from the National MPS Society about Sanfilippo syndrome.
Alliance Sanfilippo
L’Alliance Sanfilippo a été créée en 2005 par des parents d’enfants atteints de la maladie de Sanfilippo, y offre renseignements, liste de discussion, et liens utiles.
Sly Syndrome (MPS VII)
Information from the National MPS Society on Sly syndrome (MPS VII).
Explore Rare Diseases
About.com Special Features

Learn how you can reduce your your numbers with these nutrition and exercise tips. More >

Keep yourself, and your family, happy and healthy this fall with these tips. More >

  1. Home
  2. Health
  3. Rare Diseases
  4. Rare Diseases A - Z
  5. Rare Diseases: M
  6. MPS (Mucopolysaccharidosis)

©2009 About.com, a part of The New York Times Company.

All rights reserved.